Comparison of diltiazem and verapamil on rat microvascular permeability

Microvascular Research

Volumn 54, Issue 3, 1997, Pages 206-213

  Taherzadeh, Morteza ^a   Warren, John B ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Calcium channel antagonists; Edema, permeability

Indexed keywords

ALBUMIN; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; EVANS BLUE; HUMAN SERUM ALBUMIN; IODINE 125; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CREMASTER MUSCLE; EDEMA; HYDROSTATIC PRESSURE; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; SCROTUM; SKIN BLOOD FLOW; SKIN EDEMA; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULAR ENDOTHELIUM; VENULE;

ANIMALIA;

EID: 0031885361     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1997.2040     Document Type: Article

References (27)

1. Agostoni, P., De Cesar, N., Doria, E., Poleses, A., Tamborini, G., and Guazzi, M. (1986). Afterload reduction: A comparison of captopril and nifedipine in dilated cardiomyopathy. Br. Heart. J. 55, 391-399.
2. Chaouat, A., Kessler, R., and Weitzenblu, E. (1996). Pulmonary oedema and pleural effusion in two patients with primary pulmonary hypertension treated with calcium channel blockers. Heart 75, 383.
3. Curry, F. E. (1992). Modulation of venular microvessel permeability by calcium influx into endothelial cells. FASEB J. 6, 2456-2466.
4. Echizen, H., and Eichelbaum, M. (1986). Clinical pharmacokinetics of verapamil, nifedipine and diltiazem. Clin. Pharmacokinet. 11, 425-449.
5. Friedland, S., Kaplan, S., Lahav, M., and Shapiro, A. (1993). Proptosis and periorbital edema due to diltiazem treatment. Arch. Ophthalmol. 111, 1027-1028.
6. Giles, T. (1996). The cost-effective way forward for management of the patient with heart failure. Cardiology 87(1), 33-39.
7. Guazzi, M. D., De Cesar, N., Galli, C., Salvioni, A., Tramontana, C., Tamborinin, G., and Bartorelli, A. (1984). Calcium-channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension. Circulation 70(2), 279-284.
8. Gustafsson, D. (1987). Microvascular mechanisms involved in calcium antagonist edema formation. J. Cardiovasc. Pharmacol. 10, S121-131.
9. Johnson, J. M. (1990). The cutaneous circulation. In "Laser-Doppler Blood Flowmetry" (A. P. Shepherd and P. A. Oberg, Eds.), pp. 201-213. Kluwer, Dordrecht.
10. Joris, I., DeGirolami, U., and Majno, G. (1982). Vascular labeling with Monastral blue B. Stain Technol. 57(3), 177-183.
11. Lewis, J. G. (1983). Adverse reactions to calcium antagonists. Drugs 25, 196-222.
12. Lynch, P., Dargie, H., Krikler, S., and Krikler, D. (1980). Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination. Br. Med. J. 281, 184-187.
13. Majno, G., Palade, E., and Schoefl, G. I. (1961). The site of action of histamine and serotonin along the vascular tree: A topographic study. J. Biophys. Biochem. Cytol. 11, 607-625.
14. Murad, F. (1990). Drugs used for the treatment of angina: Organic nitrates, calcium-channel blockers, and β-adrenergic antagonists. In "Goodman and Gilman's The Pharmacological Basis of Therapeutics" (A. Goodman Gilman, T. W. Rall, A. S. Nies, and P. Taylor, Eds.), pp. 764-783. McGraw-Hill, New York.
15. Nilsson, G. E. (1990). Perimed's LDV flowmeter. In "Laser-Doppler Blood Flowmetry" (A. P. Shepherd and P. A. Oberg, Eds.), pp. 121-139. Kluwer, Dordrecht.
16. Pfeffer, M. A., Braunwald, E., and Moye, L. A. (1992). Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 327, 669-677.
17. Renkin, E. M. (1992). Cellular and intercellular transport pathways in exchange vessels. Am. Rev. Respir. Dis. 146, S28-S31.
18. Salameh, A., Schomecker, G., Breitkopf, K., Dhein, S., and Klaus, W. (1996). The effect of calcium-antagonist nitrendipine on intracellular calcium concentration in endothelial cells. Br. J. Pharmacol. 118, 1899-1904.
19. Salmasi, A., Belcaro, G., and Nicolaides, A. N. (1991). Impaired veno-arteriolar reflex as a positive cause for nifedipine-induced ankle oedema. Int. J. Cardiol. 30, 303-307.
20. Taherzadeh, M., and Warren, J. B. (1997a). Nifedipine induced oedema forms via post-capillary venules. Clin. Sci. 92(2), 9. [abstract].
21. Taherzadeh, M., and Warren, J. B. (1997b). Nifedipine induced oedema and the role of microvascular vasodilation. Br. J. Pharmacol. 120, 23.
22. Tordjman, K., Rosenthal, T., and Bursztyn, M. (1985). Nifedipine induced periorbital edema. Am. J. Cardiol. 55, 1445.
23. Valentin, J. P., Ribstein, J., and Mimran, A. (1989). Effect of nicardipine and atriopeptin on transcapillary shift of fluid and proteins. Am. J. Physiol. 257, R174-R179.
24. Valentin, J. P., Nafrialdi, N., Ribstein, J., and Mimran, A. (1993). Endogenous angiotensin II but not atrial natriuretic peptide modulates the effect of nicardipine on extracellular fluid partition. J. Hyperten. 11(9), 961-967.
25. Warren, J. B., Wilson, A. J., Loi, R. K., and Coughlan, M. L. (1993). Opposing roles of cyclic AMP in vascular control of edema formation. FASEB J. 7, 1394-1400.
26. 2 is an intermediate in agonist-stimulated nitric oxide release in rabbit skin microcirculation. Am. J. Physiol. 266, H1846-H1853.
27. Williams, S. A., Rayman, G., and Tooke, J. E. (1989). Dependent oedema and attenuation of postural vasoconstriction associated with nifedipine therapy for hypertension in diabetic patients. Eur. J. Clin. Pharmacol. 37, 333-335.